For research use only. Not for therapeutic Use.
Aripiprazole monohydrate (Cat.No:I022425) is a medication used to treat mental or mood disorders, such as schizophrenia, bipolar disorder, or major depressive disorder. It works by changing the balance of certain natural substances in the brain.
| Catalog Number | I022425 |
| CAS Number | 851220-85-4 |
| Synonyms | Aripiprazole monohydrate; OPC 14597; OPC14597; OPC-14597; OPC 31; OPC-31; OPC31; Abilitat; |
| Molecular Formula | C23H29Cl2N3O3 |
| Purity | 99% |
| Target | Neuronal Signaling |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| IUPAC Name | 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one hydrate |
| InChI | 1S/C23H27Cl2N3O2.H2O/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18;/h3-6,8,16H,1-2,7,9-15H2,(H,26,29);1H2 |
| InChIKey | UXQBDXJXIVDBTF-UHFFFAOYSA-N |
| SMILES | ClC1=C(Cl)C(N2CCN(CCCCOC3=CC(NC(CC4)=O)=C4C=C3)CC2)=CC=C1.O |
| Reference | 1: Cameron C, Zummo J, Desai D, Drake C, Hutton B, Kotb A, Weiden PJ. Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies. Curr Med Res Opin. 2018 Apr;34(4):725-733. doi: 10.1080/03007995.2017.1410471. Epub 2018 Jan 10. PubMed PMID: 29179595. |
